ACTIVE GRANTS
-
Title: Las vesículas Extracelulares como mensajeros en la Diabetes Gestacional: Comprender las alteraciones metabólicas y las firmas predictivas. (PI24/01451).
Funding entity: Instituto de Salut Carlos III.
Duration: 2025-2028
Principal Investigator: Ana Megia Colet, PhD.
-
Title: The usefulness of circulating microvesicles (host and bacterial) in regulating metabolic homeostasis in obesity Randomized study of parallel arms in obese patients undergoing caloric restriction diet vs.early time-restricted eating (PI23/01133).
Funding entity: Instituto de Salut Carlos III.
Duration: 2024-2027
Principal Investigator: Joan Vendrell Ortega, PhD.
-
Title: Circulating extracellular vesicles as key regulators of the interplay between gut microbiota and host metabolism: Preclinical studies in obese mice undergoing dietary interventions and mechanistic studies. (PI23/01230).
Funding entity: Instituto de Salut Carlos III.
Duration: 2024-2027
Principal Investigator: Victoria Ceperuelo, PhD.
-
Title: Role of circulating extracellular vesicles (host and bacterial) in the homeostasis balance after bariatric surgery in morbidly obese patients. Analysis as biomarkers of weight loss effectiveness and diabetes remission in three cohorts (PI23/01289).
Funding entity: Instituto de Salut Carlos III.
Duration: 2024-2027
Principal Investigator: Ana Silvia Pellitero Rodriguez, PhD.
-
Title: The role of circulating extracellular vesicles (host and bacterial) on metabolic homeostasis and as interorgan communicators in patients with type 1 diabetes and non-alcoholic fatty liver disease (PI23/00071).
Funding entity: Instituto de Salut Carlos III.
Duration: 2024-2027
Principal Investigator: Gemma Llauradó Cabot, PhD.
-
Title: HostMetEV. Unveiling the role of circulating extracellular vesicles in host metabolism (CNS2023-143826).
Funding entity: Agencia Estatal de Investigación. Ministerio de Ciencia, Innovación y Universidades.
Duration: 2024-2026
Principal Investigator: Victoria Ceperuelo, PhD.
-
Title: Succinate/SUCNR1 axis in liver. From the physiology to NAFLD progression: Basic and Clinical approach, SUC-LIVE (PID2021-122480OB-100).
Funding entity: Ministerio de Ciencia e Innovación.
Duration: 2022-2025
Principal Investigator: Sonia Fernández-Veledo, PhD.
-
Title: Ensayo clinico en fase IIa para evaluar la seguridad y eficacia del tratamiento con células troncales alogénicas mesenquimales derivadas de la grasa en pacientes con estenosis inflamatoria única en el contexto de la Enfermedad de Crohn (ICI21/00038).
Funding entity: Instituto de Salud Carlos III.
Duration: 2022-2026
Principal Investigator: Joan Vendrell Ortega, PhD.
-
Title: NEUROinflammatory role of the succinate/SUCNR1 axis in obesity-related DIAbetes (NEURO_DIA).
Funding entity: European Foundation for the Study of Diabetes.
Duration: 2022-2024
Principal Investigator: Sonia Fernández-Veledo, PhD.
Collaboration. co-IP: Luca Peruzzotti-Jametti, MD, PhD.
-
Title: Oxilipinas en la diabetes gestacional y su relación con el fenotipo materno y de la descendencia (PI21/1479).
Funding entity: Instituto de Salud Carlos III
Duration: 2022-2024
Principal Investigator: Ana Megia Colet, PhD.
Project Website: www.oxigenstudy.com
-
Title: Estrategias de control y estudio fármaco-genético para el tratamiento personalizado del hígado graso asociado a disfunción metabólica en pacientes con prediabetes: Estudio PROMETEO-HG (ICI20/00069).
Funding entity: Instituto de Salud Carlos III.
Duration: 2021 – 2025
Principal Investigator: Joan Vendrell Ortega, MD, PhD.
Coordinator: José Lopez Miranda.
-
Title: Diabetic Retinopathy risk assessment using image-based deep learning and clinical (ID:210008).
Funding entity: EIT Health.
Duration: 2021-2024
Principal Investigator: Joan Vendrell Ortega, PhD.
-
Title: Succinate as a novel extracellular signalling metabolite regulating atherosclerosis development (PID2020-119030RJ-I00).
Funding entity: Ministerio de Ciencia e Innovación.
Duration: 2021-2024
Principal Investigator: Lídia Cedó Giné, PhD.
-